SMTL ID : 8t6f.1

Crystal structure of human MBP-Myeloid cell leukemia 1 (Mcl-1) in complex with BRD810 inhibitor

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.56 Å
Oligo State
monomer
Ligands
1 x GLC- GLC: alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
1 x MG: MAGNESIUM ION(Non-covalent)
1 x YI7: (3aM,9S,15R)-4-chloro-3-ethyl-7-{3-[(6-fluoronaphthalen-1-yl)oxy]propyl}-2-methyl-15-[2-(morpholin-4-yl)ethyl]-2,10,11,12,13,15-hexahydropyrazolo[4',3':9,10][1,6]oxazacycloundecino[8,7,6-hi]indole-8-carboxylic acid(Non-covalent)
1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
1 x PGE: TRIETHYLENE GLYCOL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Rauh, U. et al., BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models. Nat Cancer (2024)
Release Date
2024-06-19
Peptides
Maltose/maltodextrin-binding periplasmic protein/Induced myeloid leukemia cell differentiation protein Mcl-1 Chimera: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Maltose/maltodextrin-binding periplasmic protein/Induced myeloid leukemia cell differentiation protein Mcl-1 Chimera

Related Entries With Identical Sequence

4wgi.1 | 4wms.1 | 4wmt.1 | 4wmu.1 | 4wmv.1 | 4wmw.1 | 4wmx.1 | 8g3s.1 | 8g3t.1 | 8g3u.1 | 8g3w.1 | 8g3x.1 | 8g3y.1 | 8qso.1 | 8svy.1